LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Hypertension

In brief

This study will assess the efficacy and safety of LFF269 compared to placebo after treatment in subjects with essential hypertension.

Key facts

Study ID

NCT01373086

Run by

Novartis Pharmaceuticals

People needed

19

Starts

2011-05-01

Expected to finish

2011-10-01

Last updated by the study team

2020-12-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female (post-menopausal or surgically sterile).
• Age from 18 to 75 years inclusive.
• Subjects with mild-to-moderate uncomplicated essential hypertension, with (not more than 2 in combination) or without prior treatment.
• Subjects must weigh at least 50 kg to participate in the study, and must have a body mass index (BMI) within the range of 18 - 36 kg/m2.

You may not qualify if…

• History or evidence of a secondary form of hypertension,
• History of cardiovascular disease. Type 1 or type 2 diabetes mellitus.
• Clinically significant valvular heart disease.
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Advanced Clinical Research Institute-Phase I — Anaheim, California, United States
• Comprehensive Phase I — Fort Myers, Florida, United States
• Comprehensive Phase One®, — Miramar, Florida, United States
• Comprehensive NeuroScience — St. Petersburg, Florida, United States
• Clinical Research Atlanta — Stockbridge, Georgia, United States
• Clinical Research Advantage/ Prairie Fields Family Medicine, PC — Fremont, Nebraska, United States
• Internal Medicine Physicians — Omaha, Nebraska, United States
• ICON Developmental Solutions — Omaha, Nebraska, United States
• Clinical Research Advantage/ Aloha Medical — Las Vegas, Nevada, United States
• ICON Development Solutions, — San Antonio, Texas, United States
• Comprehensive Clinical Development NW, Inc. — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.